| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.3 | 0.07 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.28 | 0.08 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |